Movement Alert｜JD Health Rises 3.23% in Regular Trading, Internet Healthcare Sector Broadly Strengthens as UBS Maintains Buy Rating

Market Focus07-10

On July 10, JD Health rose 3.23% in regular trading, trading at 37.76 HKD/share, with turnover of approximately 64.18 million HKD.

On the news front, the Internet & Direct Marketing Retail sector broadly strengthened, with positive industry sentiment lifting JD Health in tandem. Among sector peers, BABA-W rose 4.35%, PA Good Doctor rose 4.20%, ALI Health rose 2.94%, and JD-SW rose 2.88%.

Additionally, UBS recently maintained its Buy rating on JD Health, noting the company has established competitive advantages at both the user and supply chain levels on its online platform. The bank expects the online pharmacy platform revenue to achieve a double-digit compound annual growth rate, while also noting that regulatory tightening will have limited impact on online drug purchasing behavior. UBS simultaneously maintained a Sell rating on Ali Health and lowered its target price from 3.6 HKD to 3.1 HKD, underscoring a differentiated outlook favoring JD Health within the sector.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1105880809?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-10 10:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105880809","market":"hk","top_or_hot":-1,"title":"Movement Alert｜JD Health Rises 3.23% in Regular Trading, Internet Healthcare Sector Broadly Strengthens as UBS Maintains Buy Rating","media":"Market Focus","content":"<p><p>On July 10, JD Health rose 3.23% in regular trading, trading at 37.76 HKD/share, with turnover of approximately 64.18 million HKD.</p><p>On the news front, the Internet & Direct Marketing Retail sector broadly strengthened, with positive industry sentiment lifting JD Health in tandem. Among sector peers, BABA-W rose 4.35%, PA Good Doctor rose 4.20%, ALI Health rose 2.94%, and JD-SW rose 2.88%.</p><p>Additionally, UBS recently maintained its Buy rating on JD Health, noting the company has established competitive advantages at both the user and supply chain levels on its online platform. The bank expects the online pharmacy platform revenue to achieve a double-digit compound annual growth rate, while also noting that regulatory tightening will have limited impact on online drug purchasing behavior. UBS simultaneously maintained a Sell rating on Ali Health and lowered its target price from 3.6 HKD to 3.1 HKD, underscoring a differentiated outlook favoring JD Health within the sector.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜JD Health Rises 3.23% in Regular Trading, Internet Healthcare Sector Broadly Strengthens as UBS Maintains Buy Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜JD Health Rises 3.23% in Regular Trading, Internet Healthcare Sector Broadly Strengthens as UBS Maintains Buy Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-10 10:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 10, JD Health rose 3.23% in regular trading, trading at 37.76 HKD/share, with turnover of approximately 64.18 million HKD.</p><p>On the news front, the Internet & Direct Marketing Retail sector broadly strengthened, with positive industry sentiment lifting JD Health in tandem. Among sector peers, BABA-W rose 4.35%, PA Good Doctor rose 4.20%, ALI Health rose 2.94%, and JD-SW rose 2.88%.</p><p>Additionally, UBS recently maintained its Buy rating on JD Health, noting the company has established competitive advantages at both the user and supply chain levels on its online platform. The bank expects the online pharmacy platform revenue to achieve a double-digit compound annual growth rate, while also noting that regulatory tightening will have limited impact on online drug purchasing behavior. UBS simultaneously maintained a Sell rating on Ali Health and lowered its target price from 3.6 HKD to 3.1 HKD, underscoring a differentiated outlook favoring JD Health within the sector.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1105880809","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105880809","pubTimestamp":1783649686,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 10, JD Health rose 3.23% in regular trading, trading at 37.76 HKD/share, with turnover of approximately 64.18 million HKD.On the news front, the Internet & Direct Marketing Retail sector...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"走势提醒|京东健康常规交易上涨3.23%，瑞银维持买入评级，互联网医疗板块普遍走强","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"On July 10, JD Health rose 3.23% in regular trading, trading at 37.76 HKD/share, with turnover of approximately 64.18 million HKD.On the news front, the Internet & Direct Marketing Retail sector broadly strengthened, with positive industry sentiment lifting JD Health in tandem. Among sector peers, BABA-W rose 4.35%, PA Good Doctor rose 4.20%, ALI Health rose 2.94%, and JD-SW rose 2.88%.Additionally, UBS recently maintained its Buy rating on JD Health, noting the company has established competitive advantages at both the user and supply chain levels on its online platform. The bank expects the online pharmacy platform revenue to achieve a double-digit compound annual growth rate, while also noting that regulatory tightening will have limited impact on online drug purchasing behavior. UBS simultaneously maintained a Sell rating on Ali Health and lowered its target price from 3.6 HKD to 3.1 HKD, underscoring a differentiated outlook favoring JD Health within the sector.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1105880809","isCrawlerRequest":true}